CDK2 and nasopharyngeal carcinoma: Therefore, we detected the expression of downstream targets of E2F-1, including cyclin E1 and CDK2 [40–43], and consequently, E2F-1 downregulation further reduced the expression of cyclin E1 and CDK2 in DDP-resistant NPC cells.